Eric has 20 years of experience in HEOR. He is a global expert in health technology assessment, having supported clients with reimbursement submissions to NICE, SMC, IQWiG, NOMA, HAS, CADTH, and others, in a wide-variety of therapeutic areas, including but not limited to oncology, diabetes, cardiovascular disease, rare diseases, and hepatitis. Eric is also a leading methodologist, having led or advised on more than 400 systematic reviews, 200 comparative effectiveness analyses (e.g. network meta-analysis, matching-adjusted indirect comparisons) and 100 economic evaluations (e.g. cost-utility analyses, budget impact models). Eric has completed graduate work in health technology assessment, evidence synthesis, and health economics at the University of British Columbia, the University of Victoria, the University of Oxford, and the University of Glasgow. He has published over 75 peer-reviewed papers. Eric has been ranked as the 10th most prolific author in network meta-analysis.